<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03072212</url>
  </required_header>
  <id_info>
    <org_study_id>01/31-17</org_study_id>
    <nct_id>NCT03072212</nct_id>
  </id_info>
  <brief_title>Impact of HIV-infection on Clinical Characteristics and Outcomes on Stroke in Uganda</brief_title>
  <official_title>Impact of HIV-infection on Clinical Characteristics and Outcomes on Stroke in Uganda</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mbarara University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mbarara University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will recruit participants from three tertiary care hospitals in Uganda into&#xD;
      an observational cohort study of people living with HIV/AIDS (PLWHA) and HIV-uninfected&#xD;
      persons matched for gender and residency, presenting with CT-confirmed stroke. We will&#xD;
      collect socio demographic, clinical, laboratory, radiologic, cardiac, and clinical neurologic&#xD;
      disease measures to investigate the effect of HIV-infection on 1) clinical and radiologic&#xD;
      presentation, 2) risk factor profiles; and 3) stroke outcomes (death or disability).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will enroll 100 HIV-infected adults presenting to the emergency department&#xD;
      with acute or sub-acute stroke (within 14 days of onset) confirmed by computed tomography&#xD;
      (CT) scan at Mbarara Regional Referral, Mulago National Referral, and Nsambya Hospitals in&#xD;
      Uganda. We will also enroll 100 HIV-uninfected controls, also presenting with acute or&#xD;
      sub-acute stroke, matched by gender and county/district of residence. Participants will be&#xD;
      followed for up to one year after enrollment. We plan to complete the following research&#xD;
      aims:&#xD;
&#xD;
      Aim 1: To identify the impact of HIV-infection on outcomes after acute or sub-acute stroke in&#xD;
      Uganda. Our primary outcome will be poor stroke outcome defined as mortality or poor&#xD;
      functional status (modified Rankin Scale [mRS] &gt; 2). The investigators will assess for&#xD;
      mortality and functional status at one, three, six, and 12 months after presentation. We will&#xD;
      estimate the relative risk of poor outcome by HIV serostatus in both unadjusted models and&#xD;
      models adjusted for traditional stroke risk factors. We hypothesize that HIV-infected&#xD;
      patients have higher rates of poor stroke outcomes compared to HIV-uninfected patients, and&#xD;
      that this difference is, in part, attributable to the presence of concurrent central nervous&#xD;
      system opportunistic infections.&#xD;
&#xD;
      Aim 2: To describe the clinical and radiologic characteristics of stroke in Uganda, with&#xD;
      particular attention to differences by HIV serostatus. The investigators will describe the&#xD;
      clinical presentation of stroke, including history and physical exam findings and presenting&#xD;
      modified National Institutes of Health Stroke Scale (mNIHSS) score. The investigators will&#xD;
      also compare radiologic characteristics, including location of the stroke and its&#xD;
      classification as either ischemic or hemorrhagic. We hypothesize that: i) HIV-infected&#xD;
      patients are predominantly younger at the time of presentation, ii) HIV infected-patients&#xD;
      have more severe stroke presentations with higher mNIHHS scores, iii) HIV-infected patients&#xD;
      are more likely to suffer from ischemic (versus hemorrhagic) stroke, and that iv)&#xD;
      HIV-infected patients have a greater proportion of small vessel territory strokes due to the&#xD;
      association with central nervous system infections and basal meningitis.&#xD;
&#xD;
      Aim 3: To identify the traditional and HIV-specific risk factors for poor outcome after&#xD;
      stroke in Uganda. The investigators will fit regression models to identify predictors of poor&#xD;
      outcomes as described in Aim 1, both in the total cohort, and restricted to the HIV-infected&#xD;
      cohort. We hypothesize that age, presence of hypertension, dyslipidemia, smoking, and low&#xD;
      Glasgow coma score are associated with PSO in Uganda and that HIV-specific predictors of poor&#xD;
      outcome are low mid-upper arm circumference (MUAC), low CD4 cell count, high HIV viral load,&#xD;
      and report of recent constitutional symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Poor stroke outcome</measure>
    <time_frame>30 days follow-up</time_frame>
    <description>modified Rankin Scale [mRS] &gt; 2 or mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Poor stroke outcome</measure>
    <time_frame>1 year follow-up</time_frame>
    <description>modified Rankin Scale [mRS] &gt; 2 or mortality</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>HIV</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>HIV infected with stroke</arm_group_label>
    <description>No intervention will be administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV uninfected with stroke</arm_group_label>
    <description>No intervention will be administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational study</intervention_name>
    <description>No intervention</description>
    <arm_group_label>HIV infected with stroke</arm_group_label>
    <arm_group_label>HIV uninfected with stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population of HIV-infected and uninfected individuals are both drawn from the three&#xD;
        hospitals in geographically different parts of Uganda.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years old&#xD;
&#xD;
          -  In clinical care at the Mbarara Regional Referral, Mulago National Referral, or&#xD;
             Nsambya Hospitals&#xD;
&#xD;
          -  Hospital presentation with features of new sudden-onset signs of focal or global&#xD;
             disturbance of cerebral function lasting &gt;24 hours (unless interrupted by surgery or&#xD;
             death)&#xD;
&#xD;
          -  Stroke as presumed etiology of presentation&#xD;
&#xD;
          -  CT confirmation of stroke&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presumed non-vascular etiology of neurodeficit (ie, trauma, tumor, brain abscess)&#xD;
&#xD;
          -  Pregnant, as defined by a positive urine beta-hCG&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Siedner, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amir Abdallah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mbarara University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amir Abdallah, MD</last_name>
    <phone>+256 702447125</phone>
    <email>aamir@must.ac.ug</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mbarara Regional Referral Hospital</name>
      <address>
        <city>Mbarara</city>
        <zip>00256</zip>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Abdallah, MD</last_name>
      <phone>+256 702447125</phone>
      <email>aamir@must.ac.ug</email>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2017</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Stroke</keyword>
  <keyword>Cerebral vascular accident</keyword>
  <keyword>Uganda</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be directly entered into a database and analysed</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

